Claire Wainwright

A CFTR Potentiator in Patients with Cystic Fibrosis and the <i>G551D</i> Mutation

Bonnie W. Ramsey, Jane C. Davies, Noel G. McElvaney et al. · New England Journal of Medicine · 2011 · 2.1K citations · Full text

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>

Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

Josephine M. Bryant, Dorothy Grogono, Daniela Rodriguez-Rincon et al. · Science · 2016 · 576 citations · Full text

Medical Microbiology, Antimicrobial Resistance Gene, Pathogenic Microbiology +13

Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a <i>G551D</i> Mutation

Jane C. Davies, Claire Wainwright, Gerard J. Canny et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 499 citations · Full text

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

Félix Ratjen, Christopher Hug, Gautham Marigowda et al. · The Lancet Respiratory Medicine · 2017 · 291 citations

Pulmonary Fibrosis, Medicine, Placebo-controlled Phase 3